LOGIN
Aspirin Versus Low-Molecular-Weight Heparin For Thromboprophylaxis After Orthopaedic Surgery
March 2025
Aspirin Versus Low-Molecular-Weight Heparin For Thromboprophylaxis After Orthopaedic Surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis.
Blood Coagul Fibrinolysis. 2024 Apr 18;35(4):187–195.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Six randomized controlled trials including 23,327 patients who underwent orthopaedic surgery were included in this systematic review and meta-analysis comparing aspirin vs. low-molecular-weight heparin (LMWH) for thromboprophylaxis. Pooled outcomes of interest included venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), major bleeding, wound complications, wound infe...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.